Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies

by on 26 de juny de 2023 with No hi ha comentaris
  • Lazar, V., Girard, N., Raymond, E., Martini, J. F., Galbraith, S., Raynaud, J., . . . Felip, E., Tabernero, J., … Schilsky, R. L. (2022). Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies. Jco Precision Oncology, 6, Article e2200072. https://doi.org/10.1200/po.22.00072

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *